Related Experiment Video
Updated: Jun 6, 2026

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Cognitive enhancers for anxiety disorders.
Stefan G Hofmann1, Jasper A J Smits, Anu Asnaani
1Department of Psychology, Boston University, 648 Beacon Street, 6th Floor, Boston, MA 02215-2002, USA. shofmann@bu.edu
Cognitive-behavioral therapy (CBT) effectively treats anxiety disorders, but some patients show limited improvement. Cognitive enhancers may boost CBT efficacy by improving learning processes, offering new treatment avenues.
Area of Science:
- Psychiatry and Behavioral Science
- Neuroscience
- Pharmacology
Background:
- Cognitive-behavioral therapy (CBT) is a primary treatment for anxiety disorders.
- A notable portion of patients exhibit insufficient response to standard CBT.
- Augmenting CBT with cognitive enhancers is being explored to improve treatment outcomes.
Purpose of the Study:
- To review the current landscape of cognitive enhancers for anxiety disorders.
- To examine how cognitive enhancers can improve CBT efficacy.
- To synthesize research on augmenting learning processes in CBT.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of research on cognitive enhancers and their mechanisms of action.
- Synthesis of data on the efficacy of combined CBT and cognitive enhancer interventions.
Main Results:
- Cognitive enhancers show potential in improving learning processes targeted by CBT.
- Preliminary evidence suggests that certain enhancers may enhance CBT outcomes in anxiety.
- Further research is needed to establish optimal enhancer selection and integration protocols.
Conclusions:
- Cognitive enhancers represent a promising strategy to improve CBT effectiveness for anxiety disorders.
- Targeting learning processes with pharmacological agents could personalize and optimize anxiety treatment.
- Future clinical trials are essential to validate the therapeutic role of cognitive enhancers in anxiety management.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Drug Therapy
Antianxiety Medications
Generalized Anxiety Disorder
